Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
Ji Woo Lee, Hyung Jin Kim, Yun Mee Choe, Hee Suk Kang, Soon Ki Kim, Yong Hoon Jun, Ji Eun Lee
Ann Pediatr Endocrinol Metab. 2014;19(3):135-140.   Published online 2014 Sep 30     DOI: https://doi.org/10.6065/apem.2014.19.3.135
Citations to this article as recorded by Crossref logo
Gonadotropin-Releasing Hormone Analogs for Treatment of Central Precocious Puberty in Children Younger than 2 Years of Age
Anisha Gohil, Erica A. Eugster
The Journal of Pediatrics.2022; 244: 215.     CrossRef
Medical decision-making competence regarding puberty suppression: perceptions of transgender adolescents, their parents and clinicians
Lieke Josephina Jeanne Johanna Vrouenraets, Annelou L. C. de Vries, Marijn Arnoldussen, Sabine E. Hannema, Ramón J. L. Lindauer, Martine C. de Vries, Irma M. Hein
European Child & Adolescent Psychiatry.2022;[Epub]     CrossRef
Review: Puberty blockers for transgender and gender diverse youth—a critical review of the literature
Lynn Rew, Cara C. Young, Maria Monge, Roxanne Bogucka
Child and Adolescent Mental Health.2021; 26(1): 3.     CrossRef
An 8-year-old girl with drug hypersensitivity to first triptorelin acetate administration
Nayoung Jung, Ji Eun Lee, Dae Hyun Lim, Jeong Hee Kim
Allergy, Asthma & Respiratory Disease.2021; 9(4): 255.     CrossRef
Evaluation of hypersensitivity reactions with leuprolide acetate and triptorelin acetate in children
AzizePınar Metbulut, KezibanToksoy Adıgüzel, Candan İslamoğlu, Mehmet Boyraz, EmineDibek Mısırlıoğlu
Indian Journal of Endocrinology and Metabolism.2021; 25(6): 527.     CrossRef
Medical Options for Care of Gender Diverse and Transgender Youth
Juanita K. Hodax, Jill Wagner, Andrew C. Sackett-Taylor, Jason Rafferty, Michelle Forcier
Journal of Pediatric and Adolescent Gynecology.2020; 33(1): 3.     CrossRef
Gender dysphoria in children and adolescents: an overview
Nicos Skordis, Andreas Kyriakou, Shai Dror, Avital Mushailov, Nicolas C. Nicolaides
Hormones.2020; 19(3): 267.     CrossRef
Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty
Karen O Klein, Analía Freire, Mirta Graciela Gryngarten, Gad B Kletter, Matthew Benson, Bradley S Miller, Tala S Dajani, Erica A Eugster, Nelly Mauras
The Journal of Clinical Endocrinology & Metabolism.2020; 105(10): e3660.     CrossRef
Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty
Tarik Kirkgoz, Elif Karakoc-Aydiner, Fuat Bugrul, Zehra Yavas Abali, Didem Helvacioglu, Ayca Kiykim, Sevgi Bilgic Eltan, Nurhan Aruci Kasap, Safa Baris, Ahmet Ozen, Tulay Guran, Abdullah Bereket, Serap Turan
Hormone Research in Paediatrics.2020; 93(1): 66.     CrossRef
Triptorelin depot for the treatment of children 2 years and older with central precocious puberty
Silvano Bertelloni, Cristina Mucaria, Giampiero I. Baroncelli, Diego Peroni
Expert Review of Clinical Pharmacology.2018; 11(7): 659.     CrossRef
Transgender medicine - puberty suppression
Leonidas Panagiotakopoulos
Reviews in Endocrine and Metabolic Disorders.2018; 19(3): 221.     CrossRef
Characteristics of traditional Chinese medicine usage in children with precocious puberty: A nationwide population-based study
Yi-Chun Lin, Tung-Ti Chang, Husan-Ju Chen, Chung-Hsing Wang, Mao-Feng Sun, Hung-Rong Yen
Journal of Ethnopharmacology.2017; 205: 231.     CrossRef
GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls
Yanqin Ying, Jing Tang, Wei Chen, Zemin Cai, Wan Ting Niu
Oncotarget.2017; 8(65): 109061.     CrossRef